Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3GF8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,987
Award facts
- Contract value 100% obligated
- $40,987.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $41K, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for ENBREL 50 MG/ML SureClick auto-injectors to be delivered to Conshohocken, Pennsylvania. The contract was awarded on February 4, 2026, with an ultimate completion date of February 5, 2026, and was not designated as a set-aside procurement. The Defense Logistics Agency (DLA) is the funding federal agency, reflecting the pharmaceutical product's role in supporting military and federal healthcare systems. ENBREL is a biologic immunosuppressant used primarily for treating autoimmune conditions such as rheumatoid arthritis, and the SureClick delivery mechanism provides patients with a pre-filled, single-use auto-injector format.
This delivery order is executed under Amerisourcebergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The competitively awarded delivery order demonstrates the contractor's established capability to fulfill federal medical procurement requirements across multiple therapeutic domains and supports the Defense Health Agency and other government healthcare systems in meeting critical pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26F3GF8?
SPE2DR26F3GF8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F3GF8 worth?
The government has obligated $40,987 on SPE2DR26F3GF8.
Is contract SPE2DR26F3GF8 an order under another contract?
Yes. SPE2DR26F3GF8 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3GF8 competed?
The extent of competition for SPE2DR26F3GF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award